tiprankstipranks
Editas Medicine Inc (GB:0IFK)
LSE:0IFK

Editas Medicine (0IFK) Stock Investors

2 Followers
Based on 729,985 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.1% of all portfolios hold GB:0IFK
On average, investors allocate 2.17% of their portfolios to GB:0IFK
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding 0IFK

1.4%
Last 7
Days
5.2%
Last 30
Days
Percentages indicate the change in the number of portfolios holding GB:0IFK, out of 729,985 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

0IFK Investor Activity

No data currently available
Based on the activity of 13,711 investors who made their portfolios public
The table shows changes in 0IFK in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

0IFK Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Block
4.47%
-1.22%
-8.10%
46.31B
Technology
Trade Desk
4.61%
-0.37%
-4.72%
39.64B
Technology
ChargePoint Holdings
3.90%
-1.03%
-7.18%
567.30M
Consumer Cyclical
Micron
5.69%
+0.45%
+8.82%
124.53B
Technology
Mercadolibre
5.28%
-0.98%
-2.99%
70.72B
Consumer Cyclical
Shopify
5.69%
-0.99%
-5.66%
95.26B
Technology
Riot Platforms
5.16%
+3.19%
+1.73%
3.00B
Financial
Airbnb
4.79%
-1.04%
-5.60%
103.96B
Consumer Cyclical
Merck & Company
4.14%
-0.03%
-1.06%
321.34B
Healthcare
Marathon Digital Holdings
5.55%
+0.27%
-2.70%
5.49B
Financial
Based on the activity of 729,985 active portfolios
Open your Smart Portfolio

0IFK Investor Analysis

GB:0IFK investors under 35

Under 35

6.0%
Last 30 days
Holdings Change
10.0%
of GB:0IFK holders
are under 35
Average Segment Performance
Average P/E Ratio55.48
Beta6.58
Dividend Yield6.31%
GB:0IFK investors between 35–55

Between 35–55

5.5%
Last 30 days
Holdings Change
47.3%
of GB:0IFK holders
are between 35–55
Average Segment Performance
Average P/E Ratio59.75
Beta11.38
Dividend Yield17.85%
GB:0IFK investors over 55

Over 55

4.7%
Last 30 days
Holdings Change
42.7%
of GB:0IFK holders
are over 55
Average Segment Performance
Average P/E Ratio50.99
Beta4.10
Dividend Yield29.58%
Overview of age group and performance of GB:0IFK stock investors
See who invests in 0IFK according to age group and performance.

FAQ

How many retail Investors hold GB:0IFK?
0.1% of TipRanks' retail investors hold GB:0IFK in their portfolios.
    What is GB:0IFK Investor Sentiment?
    GB:0IFK’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of GB:0IFK in the last 7 days?
      ▼ 1.4% of TipRanks' retail investors changed their holding of GB:0IFK in the last 7 days.
        What percentage of retail investors changed their holding of GB:0IFK in the last 30 days?
        ▼ 5.2% of TipRanks' retail investors changed their holding of GB:0IFK in the last 30 days.
          What is the average age of retail investors who hold GB:0IFK?
          The average age of GB:0IFK Holders is between 35–55.
            What other stocks have GB:0IFK investors also bought?
            GB:0IFK Investors also bought SQ, TTD, CHPT, MU, MELI, SHOP, RIOT, ABNB, MRK, MARA.
              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              AGENAgenus
              AAgilent
              BAXBaxter International
              BMRNBioMarin Pharmaceutical
              CPRXCatalyst Pharma
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis